The abstract will be open to public viewing. Submit your abstract between July 1 and July 31, 2025 by 11:59 PM to reserve your spot at the symposium; again, only one form and one presenter per ...

This abstract is a sub-study of the TIGeR-PaC clinical trial. The combination product candidate (IAG), which is enabled by the FDA-cleared RenovoCath device, is currently under investigation and ...

Invited faculty are ineligible for abstract presentation. Should you have questions regarding abstracts, please email us. Abstracts with new or novel information will receive priority for acceptance.